Publications by authors named "Xuelei Pi"

Claim this Profile
R
Recombinant oncolytic virus NDV-anti-VEGFR2 enhances radiotherapy sensitivity in NSCLC by targeting VEGF signaling and impairing DNA repair.
Liang Liu, Liying Song, Tianyan Liu, Kaiyuan Hui, Chenxi Hu, Xuelei Pi

Gene Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel anti-PD-L1/IL-8 bispecific antibody BP2402 enhances antitumor immunity and modulates inflammatory signaling in triple-negative breast cancer mice model.
Liying Song, Sumin Tang, Xuelei Pi, Yuanyuan Yan, Chenxi Hu

J Transl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-α and IL-17A, in autoimmune disease models.
Zhihang Liu, Liying Song, Jiarui Yang, Han Liu, Yating Zhang, Xuelei Pi

Int Immunopharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An immuno-blocking agent targeting IL-1β and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice.
Qi Yin, Xuelei Pi, Yuanyuan Jiang, Guiping Ren, Zhihang Liu

Inflammation· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel bispecific antibody alleviates bleomycin-induced systemic sclerosis injury.
Qi Yin, Xuelei Pi, Guiping Ren, Zhihang Liu, Han Liu

Int Immunopharmacol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis